| Literature DB >> 32190659 |
Yun Jeong Jang1,2, Dahye Park1,2, Hyeong Seop Kim1,2, Chang Han Lee1,2, Ha Young Byun1,2, Chul Ho Yoon1,2, Eun Shin Lee1,2, Heesuk Shin1,2, Se-Woong Chun3, Seung-Kyu Lim3, Min-Kyun Oh1,2.
Abstract
BACKGROUND: The complications after stroke inhibit functional recovery and worsen the prognosis of patients. The implementation of a critical pathway (CP) can facilitate functional recovery after stroke by enabling comprehensive and systematic structured rehabilitation.Entities:
Mesh:
Year: 2020 PMID: 32190659 PMCID: PMC7063219 DOI: 10.1155/2020/3265950
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Critical pathway on comprehensive rehabilitation and rehabilitation department transfer in stroke patients. Impaired ADL: impaired activities of daily living; Y: yes; N: no.
Comparison of demographic and stroke characteristics before and after CP implementation.
| Before ( | After ( |
| |
|---|---|---|---|
| Age | 62.0 ± 13.1 | 63.9 ± 12.9 | 0.163 |
| Gender | 0.692 | ||
| Male | 53 (53.0%) | 433 (50.3%) | |
| Female | 47 (47.0%) | 427 (49.7%) | |
| Cause of stroke | 1.000 | ||
| Hemorrhage | 52 (52.0%) | 448 (52.1%) | |
| Infarction | 48 (48.0%) | 412 (47.9%) | |
| Side of hemiplegia | 0.236 | ||
| Right | 49 (49.0%) | 349 (40.6%) | |
| Left | 36 (36.0%) | 379 (44.1%) | |
| Bilateral | 15 (15.0%) | 132 (15.3%) | |
| Location of lesion | 0.195 | ||
| Cortical | 3 (3.0%) | 37 (4.3%) | |
| Infratentorial | 10 (10.0%) | 140 (16.3%) | |
| Subcortical | 87 (87.0%) | 683 (79.4%) |
Values are presented as the mean ± standard deviation or number (%). CP: critical pathway. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Comparison of preexisting medical conditions of stroke patients before and after CP implementation.
| Before ( | After ( |
| |
|---|---|---|---|
| Hypertension | 70 (70.0%) | 640 (74.4%) | 0.405 |
| Alcohol abuse | 38 (38.0%) | 365 (42.4%) | 0.456 |
| Diabetes mellitus | 33 (33.0%) | 236 (27.4%) | 0.292 |
| Smoking | 31 (31.0%) | 221 (25.7%) | 0.307 |
| Cardiac arrhythmia | 28 (28.0%) | 144 (16.7%) | 0.008∗∗ |
| Osteoarthritis | 25 (25.0%) | 221 (25.7%) | 0.976 |
| Dyslipidemia | 25 (25.0%) | 104 (12.1%) | 0.001∗∗ |
| Previous stroke | 20 (20.0%) | 145 (16.9%) | 0.517 |
| Coronary artery disease | 12 (12.0%) | 76 (8.8%) | 0.393 |
| Valvular heart disease | 6 (6.0%) | 76 (8.8%) | 0.440 |
| Renal failure | 5 (5.0%) | 34 (4.0%) | 0.815 |
| COPD/asthma | 4 (4.0%) | 34 (4.0%) | 1.000 |
| Deep vein thrombosis | 2 (2.0%) | 41 (4.8%) | 0.312 |
| Hydrocephalus | 2 (2.0%) | 9 (1.0%) | 0.725 |
| Seizure history | 0 (0.0%) | 6 (0.7%) | 0.867 |
Values are presented as the number (%). CP: critical pathway; COPD: chronic obstructive pulmonary disease. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Comparison of the number of stroke patients with complications before and after CP implementation.
| Before ( | After ( |
| |
|---|---|---|---|
| Poststroke shoulder pain | 78 (78.0%) | 389 (45.2%) | 0.000∗∗∗ |
| Dysphagia | 66 (66.0%) | 461 (53.6%) | 0.024∗ |
| Poststroke depression | 46 (46.0%) | 169 (19.7%) | 0.000∗∗∗ |
| Foley catheter insertion | 38 (38.0%) | 192 (22.3%) | 0.001∗∗ |
| Pneumonia | 32 (32.0%) | 82 (9.5%) | 0.000∗∗∗ |
| Urinary tract infection | 23 (23.0%) | 80 (9.3%) | 0.000∗∗∗ |
| Hydrocephalus | 21 (21.0%) | 51 (5.9%) | 0.000∗∗∗ |
| Drug reaction | 20 (20.0%) | 74 (8.6%) | 0.001∗∗ |
| Tracheostomy | 20 (20.0%) | 77 (9.0%) | 0.001∗∗ |
| Stroke progression | 19 (19.0%) | 33 (3.8%) | 0.000∗∗∗ |
| GI symptoms | 17 (17.0%) | 122 (14.2%) | 0.544 |
| Electrolyte abnormality | 12 (12.0%) | 17 (2.0%) | 0.000∗∗∗ |
| Deep vein thrombosis | 8 (8.0%) | 27 (3.1%) | 0.030∗ |
| Fall | 8 (8.0%) | 12 (1.4%) | 0.000∗∗∗ |
| Poststroke seizure | 7 (7.0%) | 13 (1.5%) | 0.001∗∗ |
| PEG | 5 (5.0%) | 16 (1.9%) | 0.095 |
| Decubitus ulcer | 3 (3.0%) | 34 (4.0%) | 0.846 |
| Heterotopic ossification | 2 (2.0%) | 3 (0.3%) | 0.151 |
Values are presented as the number (%). CP: critical pathway; GI: gastrointestinal; PEG: percutaneous endoscopic gastrostomy. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Comparison of functional states at transfer to rehabilitation center and discharge before and after CP implementation.
| Before | After |
| |
|---|---|---|---|
| Total |
|
| |
| mRS | 4.1 ± 1.0 | 4.0 ± 1.0 | 0.237 |
| Br-stage UE proximal | 3.4 ± 1.2 | 3.9 ± 1.2 | 0.000∗∗∗ |
| Br-stage UE distal | 3.4 ± 1.3 | 3.8 ± 1.3 | 0.005∗∗ |
| Br-stage LE | 3.4 ± 1.1 | 4.0 ± 1.1 | 0.000∗∗∗ |
| K-MBI (at transfer) | 35.8 ± 23.3 | 36.2 ± 23.1 | 0.863 |
| K-MBI (at discharge) | 55.9 ± 28.8 | 57.6 ± 27.1 | 0.567 |
| K-MBI gaina | 20.2 ± 16.3 | 21.4 ± 17.7 | 0.510 |
| K-MBI efficiencyb | 0.6 ± 0.7 | 0.6 ± 0.7 | 0.475 |
| Infarction |
|
| |
| mRS | 3.7 ± 1.0 | 3.6 ± 1.1 | 0.344 |
| Br-stage UE proximal | 3.2 ± 1.2 | 4.1 ± 1.1 | 0.000∗∗∗ |
| Br-stage UE distal | 3.2 ± 1.3 | 3.9 ± 1.2 | 0.000∗∗∗ |
| Br-stage LE | 3.2 ± 1.1 | 4.3 ± 1.0 | 0.000∗∗∗ |
| K-MBI (at transfer) | 35.9 ± 23.0 | 40.8 ± 22.0 | 0.143 |
| K-MBI (at discharge) | 54.8 ± 28.3 | 61.0 ± 25.4 | 0.116 |
| K-MBI gaina | 18.9 ± 15.1 | 20.1 ± 16.2 | 0.615 |
| K-MBI efficiencyb | 0.6 ± 0.9 | 0.8 ± 0.9 | 0.132 |
| Hemorrhage |
|
| |
| mRS | 4.5 ± 0.7 | 4.4 ± 0.7 | 0.342 |
| Br-stage UE proximal | 3.5 ± 1.2 | 3.6 ± 1.3 | 0.467 |
| Br-stage UE distal | 3.5 ± 1.3 | 3.6 ± 1.3 | 0.769 |
| Br-stage LE | 3.6 ± 1.1 | 3.8 ± 1.2 | 0.270 |
| K-MBI (at transfer) | 35.7 ± 23.7 | 31.9 ± 23.2 | 0.142 |
| K-MBI (at discharge) | 57.0 ± 29.4 | 54.5 ± 28.2 | 0.066 |
| K-MBI gaina | 21.3 ± 17.4 | 22.6 ± 19.0 | 0.661 |
| K-MBI efficiencyb | 0.6 ± 0.6 | 0.5 ± 0.5 | 0.320 |
Values are presented as the mean ± standard deviation. CP: critical pathway; mRS: modified Rankin Scale; Br-stage: Brunnstrom stage; UE: upper extremity; LE: lower extremity; K-MBI: Korean version of the Modified Barthel Index. aFunction at discharge: function at rehabilitation start. bGain/rehabilitation stays (days). ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Comparison of length of stay (LOS) before and after CP implementation.
| Before | After |
| |
|---|---|---|---|
| Total |
|
| |
| Time from stroke onset to RT start | 19.9 ± 20.0 | 5.5 ± 8.9 | 0.000∗∗∗ |
| Time from onset to RH transfer day | 42.4 ± 36.0 | 22.3 ± 15.5 | 0.000∗∗∗ |
| RH LOS | 64.5 ± 62.6 | 45.9 ± 32.9 | 0.004∗∗ |
| Total LOS | 84.3 ± 58.6 | 68.2 ± 42.7 | 0.009∗∗ |
| Infarction |
|
| |
| Time from stroke onset to RT start | 11.2 ± 12.1 | 1.5 ± 0.9 | 0.000∗∗∗ |
| Time from onset to RH transfer day | 31.0 ± 22.7 | 15.7 ± 10.2 | 0.000∗∗∗ |
| RH LOS | 57.2 ± 43.4 | 32.3 ± 25.4 | 0.000∗∗∗ |
| Total LOS | 85.9 ± 54.8 | 47.9 ± 30.5 | 0.000∗∗∗ |
| Hemorrhage |
|
| |
| Time from stroke onset to RT start | 27.8 ± 22.5 | 9.2 ± 11.2 | 0.000∗∗∗ |
| Time from onset to RH transfer day | 53.0 ± 42.5 | 28.4 ± 17.0 | 0.000∗∗∗ |
| RH LOS | 71.2 ± 76.0 | 58.5 ± 34.1 | 0.236 |
| Total LOS | 82.8 ± 62.5 | 86.8 ± 43.9 | 0.652 |
Values are presented as the mean ± standard deviation (days). CP: critical pathway; RT: rehabilitation therapy; RH: rehabilitation; LOS: length of stay. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.
Comparison of site of discharge before and after CP implementation.
| Before | After |
| |
|---|---|---|---|
| Total |
|
| |
| Site of discharge | 0.081 | ||
| Home | 23 (23.0%) | 276 (32.1%) | |
| Other hospitals | 77 (77.0%) | 584 (67.9%) | |
| Infarction |
|
| |
| Site of discharge | 0.000∗∗∗ | ||
| Home | 6 (12.5%) | 175 (42.5%) | |
| Other hospitals | 42 (87.5%) | 237 (57.5%) | |
| Hemorrhage |
|
| |
| Site of discharge | 0.145 | ||
| Home | 17 (32.7%) | 101 (22.5%) | |
| Other hospitals | 35 (67.3%) | 347 (77.5%) |
Values are presented as the number (%). CP: critical pathway. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001.